{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:04:18Z","timestamp":1791594258816,"version":"4.3.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.idc.2022.11.005","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T18:48:07Z","timestamp":1676486887000},"page":"103-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vaccine-Preventable Diseases in Older Adults"],"prefix":"10.1016","volume":"37","author":[{"given":"Maha","family":"Al-Jabri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rosero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie A.","family":"Saade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.idc.2022.11.005_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","article-title":"Ageing and infection","volume":"2","author":"Gavazzi","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2022.11.005_bib2","doi-asserted-by":"crossref","first-page":"882494","DOI":"10.3389\/fragi.2022.882494","article-title":"Editorial: the impact of immunosenescence and senescence of immune cells on responses to infection and vaccination","volume":"3","author":"Agrawal","year":"2022","journal-title":"Front Aging"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","article-title":"Influence of immune aging on vaccine responses","volume":"145","author":"Gustafson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"52","key":"10.1016\/j.idc.2022.11.005_bib4","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1016\/j.vaccine.2020.11.002","article-title":"Understanding immunosenescence and its impact on vaccination of older adults","volume":"38","author":"Allen","year":"2020","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.idc.2022.11.005_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib6","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.0901022","article-title":"Age-Associated Decrease in TLR Function in Primary Human Dendritic Cells Predicts Influenza Vaccine Response","volume":"184","author":"Panda","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.idc.2022.11.005_bib7","doi-asserted-by":"crossref","first-page":"110632","DOI":"10.1016\/j.exger.2019.110632","article-title":"Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses","volume":"124","author":"Crooke","year":"2019","journal-title":"Exp Gerontol"},{"issue":"2\u20133","key":"10.1016\/j.idc.2022.11.005_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/IR:22:2-3:253","article-title":"The human thymus during aging","volume":"22","author":"Haynes","year":"2000","journal-title":"Immunol Res"},{"issue":"8","key":"10.1016\/j.idc.2022.11.005_bib9","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1172\/JCI57834","article-title":"Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies","volume":"121","author":"Sasaki","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.idc.2022.11.005_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4933-2-10","article-title":"Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I. Antibody concentrations, avidity and functional activity","volume":"2","author":"Kolibab","year":"2005","journal-title":"Immun Ageing A"},{"key":"10.1016\/j.idc.2022.11.005_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1196\/annals.1386.013","article-title":"A\u00a0study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence","volume":"1089","author":"List\u00ec","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.idc.2022.11.005_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev-cellbio-011620-034148","article-title":"B\u00a0Cell Immunosenescence","volume":"36","author":"Frasca","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.idc.2022.11.005_bib13","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fimmu.2017.00706","article-title":"Functional and Homeostatic Impact of Age-Related Changes in Lymph Node Stroma","volume":"8","author":"Thompson","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib14","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1172\/JCI97377","article-title":"Lymphoid tissue fibrosis is associated with impaired vaccine responses","volume":"128","author":"Kityo","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.coi.2010.05.003","article-title":"Aging of the innate immune system","volume":"22","author":"Shaw","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.idc.2022.11.005_bib16","doi-asserted-by":"crossref","first-page":"101422","DOI":"10.1016\/j.arr.2021.101422","article-title":"Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?","volume":"71","author":"Santoro","year":"2021","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.idc.2022.11.005_bib17","doi-asserted-by":"crossref","first-page":"583019","DOI":"10.3389\/fimmu.2020.583019","article-title":"Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly","volume":"11","author":"Pereira","year":"2020","journal-title":"Front Immunol"},{"issue":"268","key":"10.1016\/j.idc.2022.11.005_bib18","doi-asserted-by":"crossref","first-page":"268ra179","DOI":"10.1126\/scitranslmed.3009892","article-title":"mTOR inhibition improves immune function in the elderly","volume":"6","author":"Mannick","year":"2014","journal-title":"Sci Transl Med"},{"issue":"10095","key":"10.1016\/j.idc.2022.11.005_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","article-title":"Influenza","volume":"390","author":"Paules","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.idc.2022.11.005_bib20","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1002\/jmv.26990","article-title":"A\u00a0brief review of influenza virus infection","volume":"93","author":"Javanian","year":"2021","journal-title":"J\u00a0Med Virol"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s40520-019-01279-3","article-title":"The burden of influenza in older adults: meeting the challenge","volume":"33","author":"Bartoszko","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib26","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","article-title":"Impact of COVID-19 outbreaks and interventions on influenza in China and the United States","volume":"12","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000319033","article-title":"Influenza in the Elderly \u2013 A Mini-Review","volume":"57","author":"Pop-Vicas","year":"2011","journal-title":"Gerontology"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib28","doi-asserted-by":"crossref","first-page":"ofz225","DOI":"10.1093\/ofid\/ofz225","article-title":"Age-Related Differences in Hospitalization Rates, Clinical Presentation, and Outcomes Among Older Adults Hospitalized With Influenza-U.S. Influenza Hospitalization Surveillance Network (FluSurv-NET)","volume":"6","author":"Czaja","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib29","doi-asserted-by":"crossref","first-page":"ofaa268","DOI":"10.1093\/ofid\/ofaa268","article-title":"Influenza With and Without Fever: Clinical Predictors and Impact on Outcomes in Patients Requiring Hospitalization","volume":"7","author":"Smith","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2022.11.005_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/irv.12316","article-title":"Should clinical case definitions of influenza in hospitalized older adults include fever?","volume":"9","author":"Falsey","year":"2015","journal-title":"Influenza Other Respir Viruses"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2022.11.005_bib31","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1016\/j.vaccine.2020.09.048","article-title":"The disease burden of influenza beyond respiratory illness","volume":"39","author":"Macias","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1017\/S0950268812002890","article-title":"Acute myocardial infarctions, strokes and influenza: seasonal and pandemic effects","volume":"141","author":"FOSTER","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib33","doi-asserted-by":"crossref","first-page":"AR","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1532-5415.2012.04048.x","article-title":"The impact of influenza on functional decline","volume":"60","author":"Gozalo","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.idc.2022.11.005_bib35","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary Bacterial Infections Associated with Influenza Pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.idc.2022.11.005_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1743-422X-8-501","article-title":"Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection","volume":"8","author":"Dhanoa","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.idc.2022.11.005_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2014.03.008","article-title":"Immunosenescence: influenza vaccination and the elderly","volume":"29","author":"Haq","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib39","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/v11040346","article-title":"Influenza Hemagglutinin and Neuraminidase: Yin\u2013Yang Proteins Coevolving to Thwart Immunity","volume":"11","author":"Kosik","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza Vaccines: Challenges and Solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.idc.2022.11.005_bib43","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1086\/599790","article-title":"Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older","volume":"200","author":"Falsey","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.idc.2022.11.005_bib44","first-page":"1525","article-title":"Comparative Immunogenicity of Enhanced Seasonal Influenza Vaccines in Older Adults: A Systematic Review and Meta-analysis","volume":"219","author":"Ng","year":"2019","journal-title":"J\u00a0Infect Dis"},{"issue":"21","key":"10.1016\/j.idc.2022.11.005_bib45","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.vaccine.2017.03.092","article-title":"Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis","volume":"35","author":"Wilkinson","year":"2017","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.idc.2022.11.005_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(17)30235-7","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial","volume":"5","author":"Gravenstein","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa1315727","article-title":"Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults","volume":"371","author":"DiazGranados","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"29","key":"10.1016\/j.idc.2022.11.005_bib48","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2013 An innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2022.11.005_bib49","author":"Adjuvanted Flu Vaccine | CDC"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","article-title":"Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis","volume":"35","author":"Domnich","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/irv.12871","article-title":"Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis","volume":"15","author":"Coleman","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.idc.2022.11.005_bib52","article-title":"Cluster-randomized trial of adjuvanted vs. non-adjuvanted trivalent influenza vaccine in 823\u00a0U.S. nursing homes","author":"McConeghy","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respir Viruses"},{"issue":"25","key":"10.1016\/j.idc.2022.11.005_bib55","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa1608862","article-title":"Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older","volume":"376","author":"Dunkle","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"47","key":"10.1016\/j.idc.2022.11.005_bib56","doi-asserted-by":"crossref","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib58","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/21505594.2021.1889812","article-title":"Pathogenicity and virulence of Streptococcus pneumoniae: Cutting to the chase on proteases","volume":"12","author":"Marquart","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.idc.2022.11.005_bib59","unstructured":"Centers for Disease Control and Prevention. 2019. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Streptococcus pneumoniae, 2019."},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.idc.2017.07.015","article-title":"Bacterial Pneumonia in Older Adults","volume":"31","author":"Henig","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/civ1214","article-title":"Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia","volume":"62","author":"Gadsby","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2022.11.005_bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2021.11.023","article-title":"Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities","volume":"115","author":"Serrano Fern\u00e1ndez","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.md.0000076005.64510.87","article-title":"Community-Acquired Pneumonia in Very Elderly Patients: Causative Organisms, Clinical Characteristics, and Outcomes","volume":"82","author":"Fern\u00e1ndez-Sab\u00e9","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.idc.2022.11.005_bib66","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1532-5415.2000.tb02607.x","article-title":"Nonspecific Presentation of Pneumonia in Hospitalized Older People: Age Effect or Dementia?","volume":"48","author":"Johnson","year":"2000","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.idc.2022.11.005_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/microbiolspec.GPP3-0019-2018","article-title":"Streptococcus pneumoniae Capsular Polysaccharide","volume":"7","author":"Paton","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib68","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1469-0691.2010.03183.x","article-title":"Streptococcus pneumoniae: virulence factors and variation","volume":"16","author":"Mitchell","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib69","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/microbiolspec.GPP3-0028-2018","article-title":"Pneumococcal Vaccination","volume":"7","author":"Briles","year":"2019","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib70","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal Capsules and Their Types: Past, Present, and Future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal Vaccination Strategies. An Update and Perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40266-013-0060-5","article-title":"Preventing Pneumococcal Disease in the Elderly","volume":"30","author":"Vila-Corcoles","year":"2013","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"35","key":"10.1016\/j.idc.2022.11.005_bib74","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1016\/j.vaccine.2013.04.085","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared with a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.idc.2022.11.005_bib76","unstructured":"Food and Drug Administration. Summary basis for regulatory action\u2014 PREVNAR20. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration, 2021. https:\/\/www.fda.gov\/media\/150388\/download."},{"key":"10.1016\/j.idc.2022.11.005_bib77","article-title":"Summary basis for regulatory action\u2014VAXNEUVANCE. Silver Spring, MD: US Department of Health and Human Services","author":"Food and Drug","year":"2021","journal-title":"Food and Drug Administration"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib79","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/infdis\/jiz652","article-title":"The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults \u226550 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence","volume":"222","author":"Tseng","year":"2020","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib80","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A\u00a0systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"van Oorschot","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib81","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.idc.2022.11.005_bib82","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/651199","article-title":"Influence of Age and Nature of Primary Infection on Varicella-Zoster Virus\u2013Specific Cell-Mediated Immune Responses","volume":"201","author":"Weinberg","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib83","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","article-title":"Herpes Zoster in the Older Adult","volume":"31","author":"John","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.idc.2022.11.005_bib84","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/21645515.2018.1560918","article-title":"Immune responses to zoster vaccines","volume":"15","author":"Levin","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"22","key":"10.1016\/j.idc.2022.11.005_bib85","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2022.11.005_bib86","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jama.2010.1983","article-title":"Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease","volume":"305","author":"Tseng","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.idc.2022.11.005_bib87","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term Persistence of Zoster Vaccine Efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib88","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwx245","article-title":"Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study","volume":"187","author":"Baxter","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.idc.2022.11.005_bib89","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.idc.2022.11.005_bib90","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib91","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm7103a2","article-title":"Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged \u226519 Years: Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022","volume":"71","author":"Anderson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"suppl_1","key":"10.1016\/j.idc.2022.11.005_bib93","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/ofid\/ofx163.1038","article-title":"Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial","volume":"4","author":"Grupping","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2022.11.005_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6702a1","article-title":"Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"67","author":"Liang","year":"2018","journal-title":"MMWR Recomm Rep"},{"issue":"12","key":"10.1016\/j.idc.2022.11.005_bib95","first-page":"365","article-title":"Tetanus surveillance --- United States, 2001-2008","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40520-021-02018-3","article-title":"Improving vaccination rates in older adults and at-risk groups: focus on pertussis","volume":"34","author":"Choi","year":"2022","journal-title":"Aging Clin Exp Res"},{"issue":"10","key":"10.1016\/j.idc.2022.11.005_bib97","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/cid\/ciy757","article-title":"The Epidemiology of Nationally Reported Pertussis in the United States, 2000\u20132016","volume":"68","author":"Skoff","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2022.11.005_bib98","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/cid\/ciz808","article-title":"Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis","volume":"71","author":"Truelove","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2022.11.005_bib99","doi-asserted-by":"crossref","first-page":"77","DOI":"10.15585\/mmwr.mm6903a5","article-title":"Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2019","volume":"69","author":"Havers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6905a1","article-title":"Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020","volume":"69","author":"Nelson","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"18","key":"10.1016\/j.idc.2022.11.005_bib101","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15585\/mmwr.mm6818a2","article-title":"Increase in Hepatitis A Virus Infections \u2014 United States, 2013\u20132018","volume":"68","author":"Foster","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib102","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/21645515.2020.1819742","article-title":"Hepatitis A vaccination and its immunological and epidemiological long-term effects \u2013 a review of the evidence","volume":"17","author":"Herzog","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.idc.2022.11.005_bib104","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.idc.2022.11.005_bib105","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S1473-3099(20)30780-5","article-title":"Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial","volume":"21","author":"Vesikari","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.idc.2022.11.005_bib106","doi-asserted-by":"crossref","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","article-title":"Universal Hepatitis B Vaccination in Adults Aged 19\u201359 Years: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022","volume":"71","author":"Weng","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"10.1016\/j.idc.2022.11.005_bib107","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2022.11.005_bib108","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/cid\/cix993","article-title":"Current Epidemiology and Trends in Meningococcal Disease\u2014United States, 1996\u20132015","volume":"66","author":"MacNeil","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2022.11.005_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"RR-01","key":"10.1016\/j.idc.2022.11.005_bib110","first-page":"1","article-title":"Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP)","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552022000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:30:09Z","timestamp":1760196609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552022000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0891552022000976"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2022.11.005","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-Preventable Diseases in Older Adults","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}